Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Neoplasms | 1 | 2025 | 57 | 0.900 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2025 | 73 | 0.900 |
Why?
|
| Biomedical Research | 1 | 2025 | 260 | 0.730 |
Why?
|
| Helicobacter Infections | 1 | 2025 | 78 | 0.450 |
Why?
|
| Anatomy | 1 | 2014 | 4 | 0.430 |
Why?
|
| Physical Therapy Specialty | 1 | 2014 | 5 | 0.430 |
Why?
|
| Dissection | 1 | 2014 | 14 | 0.430 |
Why?
|
| Laboratories | 1 | 2014 | 19 | 0.430 |
Why?
|
| Group Processes | 1 | 2014 | 17 | 0.430 |
Why?
|
| Attitude | 1 | 2014 | 73 | 0.420 |
Why?
|
| Students | 2 | 2022 | 230 | 0.410 |
Why?
|
| Arousal | 4 | 2011 | 103 | 0.400 |
Why?
|
| Teaching | 1 | 2014 | 112 | 0.390 |
Why?
|
| Learning | 1 | 2014 | 158 | 0.380 |
Why?
|
| Stomach Neoplasms | 1 | 2025 | 206 | 0.370 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2025 | 33 | 0.350 |
Why?
|
| Evoked Potentials, Auditory | 3 | 2008 | 88 | 0.270 |
Why?
|
| Electroencephalography | 3 | 2012 | 301 | 0.240 |
Why?
|
| Antibody Formation | 1 | 2026 | 51 | 0.240 |
Why?
|
| Antibodies, Viral | 1 | 2026 | 113 | 0.230 |
Why?
|
| Nursing Homes | 1 | 2026 | 111 | 0.230 |
Why?
|
| Endometrial Neoplasms | 1 | 2025 | 144 | 0.210 |
Why?
|
| Attention | 2 | 2011 | 168 | 0.210 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 3 | 2008 | 24 | 0.180 |
Why?
|
| Genes | 1 | 2011 | 32 | 0.180 |
Why?
|
| Environment | 1 | 2011 | 88 | 0.170 |
Why?
|
| United States | 2 | 2025 | 5215 | 0.160 |
Why?
|
| Carbenoxolone | 1 | 2008 | 4 | 0.150 |
Why?
|
| Mefloquine | 1 | 2008 | 5 | 0.150 |
Why?
|
| Gap Junctions | 1 | 2008 | 27 | 0.150 |
Why?
|
| Benzhydryl Compounds | 1 | 2008 | 70 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 291 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2007 | 70 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 198 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2025 | 46 | 0.120 |
Why?
|
| Reticular Formation | 1 | 2005 | 27 | 0.120 |
Why?
|
| Helicobacter pylori | 1 | 2025 | 77 | 0.110 |
Why?
|
| Humans | 9 | 2026 | 52441 | 0.110 |
Why?
|
| Nicotine | 1 | 2005 | 174 | 0.110 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 185 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 110 | 0.100 |
Why?
|
| Perception | 1 | 2014 | 121 | 0.100 |
Why?
|
| Smoking | 1 | 2007 | 514 | 0.100 |
Why?
|
| Educational Status | 1 | 2014 | 227 | 0.100 |
Why?
|
| Ethosuximide | 1 | 2012 | 5 | 0.100 |
Why?
|
| Sleep Stages | 1 | 2012 | 41 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2014 | 196 | 0.100 |
Why?
|
| Communication | 1 | 2014 | 255 | 0.090 |
Why?
|
| Perceptual Disorders | 1 | 2011 | 14 | 0.090 |
Why?
|
| Visual Perception | 1 | 2011 | 39 | 0.090 |
Why?
|
| Cold Temperature | 1 | 2011 | 52 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2012 | 168 | 0.090 |
Why?
|
| Curriculum | 1 | 2014 | 406 | 0.090 |
Why?
|
| Female | 5 | 2026 | 28277 | 0.090 |
Why?
|
| Neoplasms | 1 | 2011 | 1314 | 0.090 |
Why?
|
| Ethanol | 1 | 2012 | 334 | 0.080 |
Why?
|
| Pregnancy | 1 | 2007 | 2642 | 0.080 |
Why?
|
| Rats | 3 | 2008 | 3228 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 177 | 0.060 |
Why?
|
| Premature Birth | 1 | 2008 | 150 | 0.060 |
Why?
|
| Rhode Island | 1 | 2026 | 30 | 0.060 |
Why?
|
| Immunization Schedule | 1 | 2026 | 12 | 0.060 |
Why?
|
| Ohio | 1 | 2026 | 46 | 0.060 |
Why?
|
| Immunization, Secondary | 1 | 2026 | 26 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 1 | 2026 | 79 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 398 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 403 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 853 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2008 | 392 | 0.050 |
Why?
|
| Male | 7 | 2026 | 26874 | 0.050 |
Why?
|
| Vaccination | 1 | 2026 | 294 | 0.050 |
Why?
|
| Health Personnel | 1 | 2026 | 255 | 0.050 |
Why?
|
| Engineering | 1 | 2022 | 5 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 22 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 1558 | 0.050 |
Why?
|
| Acoustic Stimulation | 2 | 2008 | 93 | 0.050 |
Why?
|
| Minority Groups | 1 | 2022 | 136 | 0.040 |
Why?
|
| Animals | 4 | 2012 | 13485 | 0.040 |
Why?
|
| Reaction Time | 2 | 2011 | 209 | 0.040 |
Why?
|
| Injections | 1 | 2008 | 60 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 82 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2008 | 223 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2026 | 3449 | 0.040 |
Why?
|
| Sleep, REM | 1 | 2007 | 43 | 0.030 |
Why?
|
| Electrophysiology | 1 | 2007 | 70 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2007 | 113 | 0.030 |
Why?
|
| Brain Stem | 1 | 2007 | 56 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2007 | 70 | 0.030 |
Why?
|
| Cholinergic Fibers | 1 | 2005 | 8 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 2005 | 27 | 0.030 |
Why?
|
| Anti-Anxiety Agents | 1 | 2005 | 33 | 0.030 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 54 | 0.030 |
Why?
|
| Nicotinic Antagonists | 1 | 2005 | 45 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2005 | 94 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2005 | 348 | 0.030 |
Why?
|
| Neurons | 1 | 2007 | 442 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2026 | 6694 | 0.030 |
Why?
|
| Aged | 1 | 2026 | 10242 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1365 | 0.020 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2008 | 2 | 0.020 |
Why?
|
| Metallothionein | 1 | 2008 | 10 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2008 | 26 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2008 | 47 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2008 | 92 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 51 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 185 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 278 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 127 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1888 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 412 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 558 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 328 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 667 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 1096 | 0.010 |
Why?
|
| Mitochondria | 1 | 2008 | 420 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 1337 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 5899 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 6713 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 13133 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 14205 | 0.010 |
Why?
|